Association of No Evidence of Disease Activity With No Long-term Disability Progression in Multiple Sclerosis: A Systematic Review and Meta-analysis.
Dalia RotsteinJacqueline Madeleine SolomonMaria Pia SormaniXavier MontalbanXiang Y YeDina DababnehAlexandra MuccilliPrakesh Shantilal ShahPublished in: Neurology (2022)
NEDA-3 is associated with no long-term disability progression in RRMS on both low and high efficacy therapies. Further studies of early composite outcome measures incorporating easily measurable biomarkers, and longer follow-up, may help to improve on prognostic value of NEDA-3 in RRMS.